摘要
肠道菌群数量庞大且种群丰富,参与了宿主多种生理功能,具有极为重要的科学研究价值。越来越多的学者发现肠道菌群的改变是慢性肝病发生发展的重要因素。益生菌、粪便菌群移植等靶向肠道菌群的治疗策略被认为是预防或治疗肝病新颖且有效的方法。本文就肠道菌群与慢性肝病的相关研究进展进行述评。
The gut microbiota is large and abundant,which participates in a variety of physiological functions of the host and is of great scientific research value.Treatment strategies targeting gut microbiota,such as probiotics and fecal microbiota transplantation,are considered to be a novel and effective method for the prevention or treatment of liver disease.This article reviews the research progress of gut microbiota and chronic liver disease.
作者
戴婷婷
李兰娟
DAI Ting-ting;LI Lan-juan(State key laboratory for diagnosis and treatment of infectious diseases,national clinical research centre for infectious diseases,collaborative Innovation centre for diagnosis and treatment of infectious diseases,the first affiliated hospital,Zhejiang University School of Medicine,Hanghzou,310003,China)
出处
《中西医结合肝病杂志》
CAS
2021年第9期769-775,共7页
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词
肝硬化
肝癌
肠道菌群
益生菌
粪菌移植
gut microbiota
cirrhosis
hepatocellular carcinoma
probiotics
fecal microbiota transplant
